Graziewicz Maria A, Sayer Jane M, Jerina Donald M, Copeland William C
Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, DHHS, PO Box 12233, Research Triangle Park, NC 27709, USA.
Nucleic Acids Res. 2004 Jan 16;32(1):397-405. doi: 10.1093/nar/gkh213. Print 2004.
Mitochondria are major cellular targets of benzo[a]pyrene (BaP), a known carcinogen that also inhibits mitochondrial proliferation. Here, we report for the first time the effect of site-specific N2-deoxyguanosine (dG) and N6-deoxyadenosine (dA) adducts derived from BaP 7,8-diol 9,10-epoxide (BaP DE) and dA adducts from benzo[c]phenanthrene 3,4-diol 1,2-epoxide (BcPh DE) on DNA replication by exonuclease-deficient human mitochondrial DNA polymerase (pol gamma) with and without the p55 processivity subunit. The catalytic subunit alone primarily misincorporated dAMP and dGMP opposite the BaP DE-dG adducts, and incorporated the correct dTMP as well as the incorrect dAMP opposite the DE-dA adducts derived from both BaP and BcPh. In the presence of p55 the polymerase incorporated all four nucleotides and catalyzed limited translesion synthesis past BaP DE-dG adducts but not past BaP or BcPh DE-dA adducts. Thus, all these adducts cause erroneous purine incorporation and significant blockage of further primer elongation. Purine misincorporation by pol gamma opposite the BaP DE-dG adducts resembles that observed with the Y family pol eta. Blockage of translesion synthesis by these DE adducts is consistent with known BaP inhibition of mitochondrial (mt)DNA synthesis and suggests that continued exposure to BaP reduces mtDNA copy number, increasing the opportunity for repopulation with pre-existing mutant mtDNA and a resultant risk of mitochondrial genetic diseases.
线粒体是苯并[a]芘(BaP)的主要细胞靶点,苯并[a]芘是一种已知的致癌物,它还会抑制线粒体增殖。在此,我们首次报告了源自苯并[a]芘7,8 - 二醇9,10 - 环氧化物(BaP DE)的位点特异性N2 - 脱氧鸟苷(dG)和N6 - 脱氧腺苷(dA)加合物以及源自苯并[c]菲3,4 - 二醇1,2 - 环氧化物(BcPh DE)的dA加合物对DNA复制的影响,该实验使用了有和没有p55持续合成亚基的外切核酸酶缺陷型人类线粒体DNA聚合酶(polγ)。单独的催化亚基主要在BaP DE - dG加合物的对面错误掺入dAMP和dGMP,并在源自BaP和BcPh的DE - dA加合物对面掺入正确的dTMP以及错误的dAMP。在p55存在的情况下,聚合酶掺入了所有四种核苷酸,并催化了有限的跨损伤合成,越过BaP DE - dG加合物,但不能越过BaP或BcPh DE - dA加合物。因此,所有这些加合物都会导致嘌呤错误掺入,并显著阻碍引物的进一步延伸。polγ在BaP DE - dG加合物对面的嘌呤错误掺入类似于在Y家族聚合酶eta中观察到的情况。这些DE加合物对跨损伤合成的阻碍与已知的BaP对线粒体(mt)DNA合成的抑制作用一致,并表明持续接触BaP会降低mtDNA拷贝数,增加用预先存在的突变mtDNA重新填充的机会以及由此产生线粒体遗传疾病的风险。